GlaxoSmithKline Consumer Healthcare has signed a brandsswap deal with its associate company GSK Pharmaceuticals, in order to cross Rs 8,000-crore revenue mark by 2016. With this brandsswap deal, the entity can select brands and independently market, sell and distribute them. With this initiative, both the firms can increase distribution pooling in their resources.
Initially, it will market and sell GSK Pharma's over-the counter calcium and vitamin supplement Ostocalcium while GSK Pharma will market and distribute products under the consumer division’s specialized arm Glaxo Nutrition including Actibase and Actigrow nutrition supplements. The deals will involve a cost that both the listed entities will pay each other.
